Trends in antimicrobial resistance in neisseria gonorrhoeae Isolated from Guangzhou, China, 2000 to 2005 and 2008 to 2013

Sexually Transmitted Diseases

Volumn 42, Issue 1, 2015, Pages 27-29

  Cao, Wen Ling ^a,b   Liang, Jing Yao ^a,b   Li, Xiao Dong ^a,b   Bi, Chao ^a,b   Yang, Ri Dong ^a,b   Liang, Yan Hua ^a,b   Li, Ping ^a,b   Zhong, Dao Qing ^a,b   Ye, Xing Dong ^a,b   Zhang, Xi Bao ^a,b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b GUANGZHOU INSTITUTE OF DERMATOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CIPROFLOXACIN; PENICILLIN DERIVATIVE; SPECTINOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHINA; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; PENICILLIN RESISTANCE; REVIEW; TREND STUDY; DRUG EFFECTS; FEMALE; GONORRHEA; HUMAN; MALE; MICROBIAL SENSITIVITY TEST;

ANTI-BACTERIAL AGENTS; CEFTRIAXONE; CHINA; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; FEMALE; GONORRHEA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; PENICILLINS; SPECTINOMYCIN;

EID: 84919346806     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0000000000000218     Document Type: Review

References (18)

1. World Health Organization (WHO). Global incidence and prevalence of selected curable sexually transmitted infections-2008. Geneva: World Health Organization, 2012. Available at: http://www.who.int/reproductivehealth/publications/rtis/2008-STI-estimates.pdf. Accessed April 24, 2014.
2. Barbee LA, Dombrowski JC. Control of Neisseria gonorrhoeae in the era of evolving antimicrobial resistance. Infect Dis Clin North Am 2013; 27:723-737.
3. Kovari H, de Melo Oliveira MD, Hauser P, et al. Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to cefixime and ceftriaxone: Antimicrobial susceptibility data from 1990 and 2000 to 2012. BMC Infect Dis 2013; 13:603.
4. Ohnishi M, Golparian D, Shimuta K, et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 2011; 55:3538-3545.
5. Wenling C, Xibao Z, Shi F, et al. Analysis of the antibiotic sensitivity of Neisseria gonorrhoeae in Guangzhou, Peoples Republic of China. Sex Transm Dis 2000; 27:480-482.
6. World Health Organization. Sensitivity testing of Neisseria gonorrhoeae: Methodologies for use by participants in the WHO Western Pacific regional surveillance programme. In: WHO/WPR Regional Antimicro-bial Surveillance Working Group Meeting Proceedings, 1992.
7. World Health Organization (2012) Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. Available at: http://www.who.int/reproductivehealth/publications/rtis/9789241503501/en/. Accessed July 29, 2014.
8. Zheng HP, Cao WL, Wu XZ, et al. Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in Guangzhou, China, 1996-2001. Sex Transm Infect 2003; 79:399-402.
9. Yang Y, Liao M, Gu WM, et al. Antimicrobial susceptibility and molecular determinants of quinolone resistance in Neisseria gonorrhoeae isolates from Shanghai. J Antimicrob Chemother 2006; 58:868-872.
10. Su X, Jiang F, Qimuge, et al. Surveillance of antimicrobial susceptibilities in Neisseria gonorrhoeae in Nanjing, China, 1999-2006. Sex Transm Dis 2007; 34:995-999.
11. Lee H, Hong SG, Soe Y, et al. Trends in antimicrobial resistance of Neisseria gonorrhoeae isolated from Korean patients from 2000 to 2006. Sex Transm Dis 2011; 38:1082-1086.
12. Martin I, Sawatzky P, Allen V, et al. Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001-2010. Sex Transm Dis 2012; 39:316-323.
13. Ison CA, Gedney J, Harris JR, et al. Penicillinase producing gonococci: A spent force? Genitourin Med 1986; 62:302-307.
14. Dillon JR, RubenM, LiH, et al. Challenges in the control of gonorrhea in south America and the Caribbean: Monitoring the development of resistance to antibiotics. Sex Transm Dis 2006; 33:87-95.
15. The WHO Western Pacific Region Gonococcal Antimicrobial Surveillance Programme. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO western Pacific region, 2000. Commun Dis Intell 2001; 25:274-276.
16. Bignell C, FitzGerald M. UK national guideline for the management of gonorrhea in adults, 2011. Available at: http://www.bashh.org/documents/3470/3470.pdf. Accessed July 29, 2014.
17. Zhu BY, Yu RX, Yin Y, et al. Surveillance of antimicrobial susceptibilities of Neisseria gonorrhoeae in Nanning, China, 2000 to 2012. Sex Transm Dis 2014; 41:501-506.
18. Unemo M, Nicholas RA. Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhoea. Future Microbiol 2012; 7:1401-1422.